Current Approaches and Emerging Directions in HER2-resistant Breast Cancer

por Brufsky, Adam M
Publicado 2014

Predictive and Prognostic Value of the 21-Gene Recurrence Score in Hormone Receptor–positive, Node-positive Breast Cancer

por Brufsky, Adam M.
Publicado 2014

Delaying Chemotherapy in the Treatment of Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer

por Brufsky, Adam M.
Publicado 2015

Artificial intelligence-directed prognostication of breast cancer

por Nasrazadani, Azadeh, Brufsky, Adam M.
Publicado 2019

Adjuvant treatment of HER2-positive breast cancer: winning efforts continue to improve HER2-positive patient outcome long-term

por Jankowitz, Rachel C, Brufsky, Adam M
Publicado 2012

Zoledronic acid effectiveness against breast cancer metastases - a role for estrogen in the microenvironment?

por Steinman, Richard A, Brufsky, Adam M, Oesterreich, Steffi
Publicado 2012

Prognostic factors and survival of patients with brain metastasis from breast cancer who underwent craniotomy

por Leone, José Pablo, Lee, Adrian V, Brufsky, Adam M
Publicado 2015

Ovarian function suppression as a potential mechanism of chemotherapy

por Gomez Marti, Juan Luis, Nasrazadani, Azadeh, Brufsky, Adam M.
Publicado 2021

Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer

por Hyder, Tara, Bhattacharya, Saveri, Gade, Kristine, Nasrazadani, Azadeh, Brufsky, Adam M
Publicado 2021

Statins and endocrine resistance in breast cancer

por Hyder, Tara, Marti, Juan Luis Gomez, Nasrazadani, Azadeh, Brufsky, Adam M.
Publicado 2021

Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management

por Hyder, Tara, Marino, Christopher C., Ahmad, Sasha, Nasrazadani, Azadeh, Brufsky, Adam M.
Publicado 2021

Twenty-Year Follow-Up of a Phase II Trial of Taxotere/Carboplatin/Herceptin in Patients With Metastatic HER2-Positive Breast Cancer

por Gomez Marti, Juan Luis, Nasrazadani, Azadeh, Ding, Ying, Normolle, Daniel, Brufsky, Adam M
Publicado 2023

The healthcare value of the Magee Decision Algorithm™: use of Magee Equations™ and mitosis score to safely forgo molecular testing in breast cancer

por Bhargava, Rohit, Clark, Beth Z., Carter, Gloria J., Brufsky, Adam M., Dabbs, David J.
Publicado 2020

Effects of socioeconomic status and race on survival and treatment in metastatic breast cancer

por Puthanmadhom Narayanan, Susrutha, Ren, Dianxu, Oesterreich, Steffi, Lee, Adrian V., Rosenzweig, Margaret Q., Brufsky, Adam M.
Publicado 2023

Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling

por Wheeler, David S., Barrick, Stacey R., Grubisha, Melanie J., Brufsky, Adam M., Friedman, Peter A., Romero, Guillermo
Publicado 2010

SARS‐CoV‐2 research using human pluripotent stem cells and organoids

por Deguchi, Sayaka, Serrano‐Aroca, Ángel, Tambuwala, Murtaza M., Uhal, Bruce D., Brufsky, Adam M., Takayama, Kazuo
Publicado 2021

Expression of high affinity folate receptor in breast cancer brain metastasis

por Leone, José Pablo, Bhargava, Rohit, Theisen, Brian K., Hamilton, Ronald L., Lee, Adrian V., Brufsky, Adam M.
Publicado 2015

A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence

por Fournier, Marcia V., Goodwin, Edward C., Chen, Joan, Obenauer, John C., Tannenbaum, Susan H., Brufsky, Adam M.
Publicado 2019

Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis

por Klein, Molly E, Dabbs, David J, Shuai, Yongli, Brufsky, Adam M, Jankowitz, Rachel, Puhalla, Shannon L, Bhargava, Rohit
Publicado 2013

Clinical effects of prior trastuzumab on combination eribulin mesylate plus trastuzumab as first-line treatment for human epidermal growth factor receptor 2 positive locally recurr...

por Puhalla, Shannon, Wilks, Sharon, Brufsky, Adam M, O’Shaughnessy, Joyce, Schwartzberg, Lee S, Berrak, Erhan, Song, James, Vahdat, Linda
Publicado 2016